290
Views
27
CrossRef citations to date
0
Altmetric
Review

Clinical development of a novel inactivated poliomyelitis vaccine based on attenuated Sabin poliovirus strains

, &
Pages 635-644 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Rong Tang, Guifan Li, Chengfu Zhang, Hengkui Zhi, Jiahong Zhu, Jianjun Wang, Qi Liang, Yuemei Hu & Changgui Li. (2020) A phase Ⅱ, randomized, controlled trial to evaluate the safety and immunogenicity of a Sabin strain-based inactivated polio vaccine. Human Vaccines & Immunotherapeutics 16:11, pages 2641-2648.
Read now
Eleanor Barnes & Andrew J Pollard. (2011) Vaccines in clinical trials: infectious disease. Expert Review of Vaccines 10:5, pages 555-557.
Read now

Articles from other publishers (25)

Diana Kouiavskaia, Olga Mirochnitchenko, Stephanie Troy & Konstantin Chumakov. (2023) Antigenic diversity of type 1 polioviruses and its implications for the efficacy of polio vaccines. Vaccine 41:13, pages 2147-2154.
Crossref
Emmanuel J. Vidor & John F. Modlin. 2023. Plotkin's Vaccines. Plotkin's Vaccines 890 913.e14 .
E. E. Evreinova, L. M. Khantimirova, V. A. Shevtsov, V. A. Merkulov & V. P. Bondarev. (2022) Promising opportunities to improve polio vaccines. Biological Products. Prevention, Diagnosis, Treatment 22:2, pages 142-153.
Crossref
Anastasia Piniaeva, Georgy Ignatyev, Liubov Kozlovskaya, Yury Ivin, Anastasia Kovpak, Alexander Ivanov, Anna Shishova, Liliia Antonova, Yusuf Khapchaev, Irina Feldblium, Olga Ivanova, Aleksandra Siniugina & Aydar Ishmukhametov. (2021) Immunogenicity and Safety of Inactivated Sabin-Strain Polio Vaccine “PoliovacSin”: Clinical Trials Phase I and II. Vaccines 9:6, pages 565.
Crossref
Yae Kurosawa, Shigehiro Sato, Tsuneo Okuyama & Masato Taoka. (2019) Sequential two-step chromatographic purification of infectious poliovirus using ceramic fluoroapatite and ceramic hydroxyapatite columns. PLOS ONE 14:9, pages e0222199.
Crossref
K. Chumakov & A. A. Ishmukhametov. (2018) Polio Vaccines: Present and Future. Epidemiology and Vaccine Prevention 17:3, pages 4-18.
Crossref
Yuichi SOMEYA & Hiroyuki SHIMIZU. (2018) Polio vaccines and biorisk management of poliovirusesポリオワクチンとポリオウイルスのバイオリスク管理. Uirusu 68:1, pages 31-40.
Crossref
Emmanuel Vidor. 2018. Plotkin's Vaccines. Plotkin's Vaccines 841 865.e10 .
J Wolf. 2018. Comprehensive Toxicology. Comprehensive Toxicology 852 872 .
Mingbo SunChanggui Li, Wenbo XuGuoyang LiaoRongcheng Li, Jian Zhou, Yanping Li, Wei Cai, Dongmei YanYanchun CheZhifang Ying, Jianfeng Wang, Huijuan Yang, Yan Ma, Lei MaGuang Ji, Li ShiShude JiangQihan Li. (2017) Immune Serum From Sabin Inactivated Poliovirus Vaccine Immunization Neutralizes Multiple Individual Wild and Vaccine-Derived Polioviruses. Clinical Infectious Diseases 64:10, pages 1317-1325.
Crossref
Guoyang Liao, Rongcheng Li, Changgui Li, Mingbo Sun, Shude Jiang, Yanping Li, Zhaojun Mo, Jielai Xia, Zhongping Xie, Yanchun Che, Jingsi Yang, Zhifang Yin, Jianfeng Wang, Jiayou Chu, Wei Cai, Jian Zhou, Junzhi Wang & Qihan Li. (2016) Phase 3 Trial of a Sabin Strain–Based Inactivated Poliovirus Vaccine. Journal of Infectious Diseases 214:11, pages 1728-1734.
Crossref
Hiroyuki Shimizu. (2016) Development and introduction of inactivated poliovirus vaccines derived from Sabin strains in Japan. Vaccine 34:16, pages 1975-1985.
Crossref
Barbara Sanders, Martin Koldijk & Hanneke Schuitemaker. 2015. Vaccine Analysis: Strategies, Principles, and Control. Vaccine Analysis: Strategies, Principles, and Control 45 80 .
Hiromasa Okayasu, Roland W. Sutter, Hamid S. Jafari, Marina Takane & R. Bruce Aylward. (2014) Affordable Inactivated Poliovirus Vaccine: Strategies and Progress. The Journal of Infectious Diseases 210:suppl_1, pages S459-S464.
Crossref
Heleen Kraan, Paul van Herpen, Gideon Kersten & Jean-Pierre Amorij. (2014) Development of Thermostable Lyophilized Inactivated Polio Vaccine. Pharmaceutical Research 31:10, pages 2618-2629.
Crossref
Haruko Shirato, Yuichi Someya, Masaki Ochiai, Yoshinobu Horiuchi, Motohide Takahashi, Naokazu Takeda, Kengo Wakabayashi, Yasumitsu Ouchi, Yoshihiro Ota, Yoshio Tano, Shinobu Abe, Shudo Yamazaki & Takaji Wakita. (2014) A national reference for inactivated polio vaccine derived from Sabin strains in Japan. Vaccine 32:40, pages 5163-5169.
Crossref
Pauline Verdijk, Nynke Y. Rots, Monique G.C.T. van Oijen, William C. Weldon, M. Steven Oberste, Hiromasa Okayasu, Roland W. Sutter & Wilfried A.M. Bakker. (2014) Safety and immunogenicity of a primary series of Sabin-IPV with and without aluminum hydroxide in infants. Vaccine 32:39, pages 4938-4944.
Crossref
Konstantin Chumakov. 2014. Novel Technologies for Vaccine Development. Novel Technologies for Vaccine Development 87 112 .
Olen M. Kew. 2014. Viral Infections of Humans. Viral Infections of Humans 277 336 .
Pauline Verdijk, Nynke Y. Rots, Monique G.C.T. van Oijen, M. Steven Oberste, Claire J. Boog, Hiromasa Okayasu, Roland W. Sutter & Wilfried A.M. Bakker. (2013) Safety and immunogenicity of inactivated poliovirus vaccine based on Sabin strains with and without aluminum hydroxide: A phase I trial in healthy adults. Vaccine 31:47, pages 5531-5536.
Crossref
Concepción F Estívariz, Mark A Pallansch, Abhijeet Anand, Steven GF Wassilak, Roland W Sutter, Jay D Wenger & Walter A Orenstein. (2013) Poliovirus vaccination options for achieving eradication and securing the endgame. Current Opinion in Virology 3:3, pages 309-315.
Crossref
Emmanuel Vidor & Stanley A. Plotkin. 2013. Vaccines. Vaccines 573 597 .
Guoyang Liao, Rongcheng Li, Changgui Li, Mingbo Sun, Yanping Li, Jiayou Chu, Shude Jiang & Qihan Li. (2012) Safety and Immunogenicity of Inactivated Poliovirus Vaccine Made From Sabin Strains: A Phase II, Randomized, Positive-Controlled Trial. The Journal of Infectious Diseases 205:2, pages 237-243.
Crossref
Hiroyuki SHIMIZU. (2012) Poliovirus Vaccine. Uirusu 62:1, pages 57-66.
Crossref
Seol Hee Hong, Young-Ho Byun, Chung Truong Nguyen, Soo Young Kim, Baik Lin Seong, Songyong Park, Gyu-Jin Woo, Yeup Yoon, Jeong Tae Koh, Kohtaro Fujihashi, Joon Haeng Rhee & Shee Eun Lee. (2012) Intranasal administration of a flagellin-adjuvanted inactivated influenza vaccine enhances mucosal immune responses to protect mice against lethal infection. Vaccine 30:2, pages 466-474.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.